The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Radiation-Induced IFN-γ Production within the Tumor Microenvironment Influences Antitumor Immunity
Abstract
Alterations to the tumor microenvironment following localized irradiation may influence the effectiveness of subsequent immunotherapy. The objective of this study was to determine how IFN-γ influences the inflammatory response within this dynamic environment following radiotherapy. B16/OVA melanoma cells were implanted into C57BL/6 (wild-type (WT)) and IFN-γ-deficient (IFN-γ−/−) mice. Seven days after implantation, mice received 15 Gy of localized tumor irradiation and were assessed 7 days later. Irradiation up-regulated the expression of VCAM-1 on the vasculature of tumors grown in WT but not in IFN-γ−/− mice. Levels of the IFN-γ-inducible chemokines MIG and IFN-γ-inducible protein 10 were decreased in irradiated tumors from IFN-γ−/− mice compared with WT. In addition to inducing molecular cues necessary for T cell infiltration, surface MHC class I expression is also up-regulated in response to IFN-γ produced after irradiation. The role of IFN-γ signaling in tumor cells on class I expression was tested using B16/OVA cells engineered to overexpress a dominant negative mutant IFN-γ receptor (B16/OVA/DNM). Following implantation and treatment, expression of surface class I on tumor cells in vivo was increased in B16/OVA, but not in B16/OVA/DNM tumors, suggesting IFN-γ acts directly on tumor cells to induce class I up-regulation. These increases in MHC class I expression correlated with greater levels of activated STAT1. Thus, IFN-γ is instrumental in creating a tumor microenvironment conducive for T cell infiltration and tumor cell target recognition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1604 · Cited by 3,491
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359
Dufour, J. H., Dziejman, M., Liu, M. T., Leung, J. H., Lane, T. E., & Luster, A. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3195 · Cited by 1,075
Lugade, A. A., Moran, J. P., Gerber, S. A., Rose, R. C., Frelinger, J. G., & Lord, E. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7516 · Cited by 966 · cited 4×
“Localized irradiation of tumor-bearing legs was performed as described previously (17).”
BackgroundMethodSelf-citationChemokines in tissue-specific and microenvironment-specific lymphocyte homing
Campbell, J. J., & Butcher, E. C. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00096-0 · Cited by 625
Stat1-dependent and -independent pathways in IFN-γ-dependent signaling
Ramana, C. V., Gil, M. P., Schreiber, R. D., & Stark, G. R. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02118-4 · Cited by 555
Activation of the STAT Signaling Pathway Can Cause Expression of Caspase 1 and Apoptosis
Chin, Y. E., Kitagawa, M., Kuida, K., Flavell, R. A., & Fu, X.-Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5328 · Cited by 521
Radiation and the microenvironment – tumorigenesis and therapy
Barcellos-Hoff, M. H., Park, C., & Wright, E. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1735 · Cited by 513
Combining radiotherapy and immunotherapy: A revived partnership
Demaria, S., Bhardwaj, N., McBride, W. H., & Formenti, S. C. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.06.032 · Cited by 375
Cell adhesion molecules mediate radiation-induced leukocyte adhesion to the vascular endothelium.
Hallahan, D. E., Kuchibhotla, J., & Wyble, C. W. (1996) · PubMed · Cited by 358
Khodarev, N. N., Beckett, M., Labay, E., Darga, T., Roizman, B., & Weichselbaum, R. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308102100 · Cited by 326
Coughlin, C. M., Salhany, K. E., Gee, M. S., LaTemple, D. C., Kotenko, S., Ma, X., Gri, G., Wysocka, M., Kim, J. E., Liu, L., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80585-3 · Cited by 324
A Sense of Danger from Radiation1
McBride, W. H., Chiang, C.-S., Olson, J. L., Wang, C.-C., Hong, J.-H., Pajonk, F., Dougherty, G. J., Iwamoto, K. S., Pervan, M., & Liao, Y.-P. (2004) · Radiation Research · doi:10.1667/rr3196 · Cited by 323
A primer on cytokines: sources, receptors, effects, and inducers
Curfs, J. H., Meis, J. F., & Hoogkamp-Korstanje, J. A. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.4.742 · Cited by 317
STAT proteins as novel targets for cancer drug discovery
Turkson, J. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.5.409 · Cited by 295
Role of Inflammatory Mediators in Angiogenesis
Naldini, A., & Carraro, F. (2005) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010053622830 · Cited by 287
IFNγ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway
Fulda, S., & Debatin, K.-M. (2002) · Oncogene · doi:10.1038/sj.onc.1205255 · Cited by 260
THE ROLE OF CXC CHEMOKINES AS REGULATORS OF ANGIOGENESIS
Strieter, R. M., Polverini, P. J., Arenberg, D. A., & Kunkel, S. L. (1995) · Shock · doi:10.1097/00024382-199509000-00001 · Cited by 236
Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells
Huang, S., Bucana, C. D., Arsdall, M. V., & Fidler, I. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205341 · Cited by 172
IFN-γ Expression in Macrophages and Its Possible Biological Significance
Gessani, S., & Belardelli, F. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)00007-0 · Cited by 166
Regulation of the expression and processing of caspase-12
Kalai, M., Lamkanfi, M., Denecker, G., Boogmans, M., Lippens, S., Meeus, A., Declercq, W., & Vandenabeele, P. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200303157 · Cited by 138
Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes.
Ganss, R., & Hanahan, D. (1998) · PubMed · Cited by 132
The role of IFN-γ in tumor transplantation immunity and inhibition of chemical carcinogenesis
Blankenstein, T. J. F., & Qin, Z. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00007-4 · Cited by 122
Yang, J., & Richmond, A. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.01.010 · Cited by 116
Mukai, S., Kjærgaard, J., Shu, S., & Plautz, G. E. (1999) · PubMed · Cited by 108
Regulation of Tumor Growth by IFN-Γ in Cancer Immunotherapy
Beatty, G. L., & Paterson, Y. Y. W. (2001) · Immunologic Research · doi:10.1385/ir:24:2:201 · Cited by 103
Min, W., Pober, J. S., & Johnson, D. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3174 · Cited by 101
Transformation of the microvascular system during multistage tumorigenesis
Ryschich, E., Schmidt, J., Hämmerling, G. J., Klar, E., & Ganß, R. (2002) · International Journal of Cancer · doi:10.1002/ijc.10074 · Cited by 97
STAT1 as a New Molecular Target of Anti-Inflammatory Treatment
de Prati, A. C., Ciampa, A. R., Cavalieri, E., Zaffini, R., Darra, E., Menegazzi, M., Suzuki, H., & Mariotto, S. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054546645 · Cited by 94
Tumours can act as adjuvants for humoral immunity
Brown, D. M., Fisher, T., Wei, C., Frelinger, J. G., & Lord, E. M. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01213.x · Cited by 92
Self-citationBrucet, M., Marques, L., Sebastián, C., Lloberas, J., & Celada, A. (2004) · Genes and Immunity · doi:10.1038/sj.gene.6364035 · Cited by 87
Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity
Palmer, K., Hitt, M., Emtage, P. C. R., Gyorffy, S., & Gauldie, J. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301386 · Cited by 68
Abril, E., Real, L. M., Serrano, A., Jiménez, P., Garcia-Lora, A. M., Cantón, J., Trigo, I. A., Garrido, F., & Ruiz‐Cabello, F. (1998) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050511 · Cited by 66
Leukocyte recruitment at sites of tumor: dissonant orchestration
Carlos, T. M. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.2.171 · Cited by 62
Dobrzanski, M. J., Reome, J. B., & Dutton, R. W. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4945 · Cited by 52
In vivo interferon regulatory factor 3 tumor suppressor activity in B16 melanoma tumors.
Duguay, D., Mercier, F., Stagg, J., Martineau, D., Bramson, J. L., Servant, M. J., Lin, R., Galipeau, J., & Hiscott, J. B. (2002) · PubMed · Cited by 49
Liu, K., & Abrams, S. I. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6329 · Cited by 46
Abdel-Wahab, Z., Dar, M. M., Hester, D., Vervaert, C. E., Gangavalli, R., Barber, J. R., Darrow, T. L., & Seigler, H. F. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0200 · Cited by 46
IL-17 reduces TNF-induced Rantes and VCAM-1 expression
Schnyder, B., Schnyder‐Candrian, S., Pansky, A., Schmitz, M. L., Heim, M. H., Ryffel, B., & Moser, R. (2005) · Cytokine · doi:10.1016/j.cyto.2005.02.012 · Cited by 41
Dominiecki, M. E., Beatty, G. L., Pan, Z.-K., Neeson, P. J., & Paterson, Y. Y. W. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0610-0 · Cited by 33
Svane, I. M., ENGEL, A. ‐., Nielsen, M. B., & Werdelin, O. (1997) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1997.d01-141.x · Cited by 23
Moran, J. P., Gerber, S. A., Martin, C. A., Frelinger, J. G., & Lord, E. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11284 · Cited by 7
Self-citationHatina, J., Jansa, P., & Reischig, J. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002320271323 · Cited by 7
Isolation and expansion of tumor-infiltrating lymphocytes.
Woods, M. L., McAdam, A. J., Frelinger, J. G., & Lord, E. (1993) · PubMed · Cited by 4
Self-citation
Cited by
Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
Formenti, S. C., & Demaria, S. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs629 · Cited by 1,053
Systemic effects of local radiotherapy
Formenti, S. C., & Demaria, S. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70082-8 · Cited by 1,021
Chemokines and the immune response to cancer
Ozga, A. J., Chow, M. T., & Luster, A. D. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.012 · Cited by 830
Role of Local Radiation Therapy in Cancer Immunotherapy
Demaria, S., Golden, E. B., & Formenti, S. C. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2756 · Cited by 779
Cold and hot tumors: from molecular mechanisms to targeted therapy
Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 682
Metadata
- Authors
- Lugade, A. A., Sorensen, E. W., Gerber, S. A., Moran, J. P., Frelinger, J. G., & Lord, E. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-03-01
- Volume
- 180
- Issue
- 5
- Pages
- 3132-3139
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1839872679
- Cited by
- 485
- References
- 49
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.